A new trading day began on Tuesday, with Catalent Inc. (NYSE: CTLT) stock price up 0.07% from the previous day of trading, before settling in for the closing price of $56.16. CTLT’s price has ranged from $31.80 to $60.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 15.24% over the past five years. Meanwhile, its annual earnings per share averaged -95.30%. With a float of $175.94 million, this company’s outstanding shares have now reached $180.00 million.
Let’s look at the performance matrix of the company that is accounted for 17800 employees.
Catalent Inc. (CTLT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Catalent Inc. is 2.79%, while institutional ownership is 94.95%. The most recent insider transaction that took place on Jun 04 ’24, was worth 76,023. In this transaction Pres. BioProduct Delivery, CoS of this company sold 1,401 shares at a rate of $54.26, taking the stock ownership to the 20,617 shares. Before that another transaction happened on Mar 15 ’24, when Company’s SVP, Quality & Reg. Affairs sold 387 for $56.20, making the entire transaction worth $21,749. This insider now owns 29,506 shares in total.
Catalent Inc. (CTLT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -95.30% per share during the next fiscal year.
Catalent Inc. (NYSE: CTLT) Trading Performance Indicators
Here are Catalent Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.36, a number that is poised to hit 0.47 in the next quarter and is forecasted to reach 1.14 in one year’s time.
Technical Analysis of Catalent Inc. (CTLT)
Catalent Inc. (NYSE: CTLT) saw its 5-day average volume 1.77 million, a negative change from its year-to-date volume of 2.23 million. As of the previous 9 days, the stock’s Stochastic %D was 73.19%. Additionally, its Average True Range was 0.59.
During the past 100 days, Catalent Inc.’s (CTLT) raw stochastic average was set at 46.62%, which indicates a significant decrease from 73.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 14.13% in the past 14 days, which was higher than the 10.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $55.61, while its 200-day Moving Average is $49.96. Nevertheless, the first resistance level for the watch stands at $56.33 in the near term. At $56.46, the stock is likely to face the second major resistance level. The third major resistance level sits at $56.64. If the price goes on to break the first support level at $56.03, it is likely to go to the next support level at $55.85. The third support level lies at $55.72 if the price breaches the second support level.
Catalent Inc. (NYSE: CTLT) Key Stats
With a market capitalization of 10.17 billion, the company has a total of 180,980K Shares Outstanding. Currently, annual sales are 4,263 M while annual income is -256,000 K. The company’s previous quarter sales were 1,074 M while its latest quarter income was -101,000 K.
